
Zenlabs Ethica Falls to 52-Week Low of Rs.25 Amidst Prolonged Downtrend
2025-12-04 10:15:53Zenlabs Ethica, a player in the diversified commercial services sector, has reached a new 52-week low of Rs.25, marking a significant decline amid a sustained period of negative returns and valuation pressures.
Read MoreWhy is Zenlabs Ethica falling/rising?
2025-12-03 00:52:45Persistent Downtrend Against Market Benchmarks Zenlabs Ethica’s recent price movement underscores a challenging period for the stock. Over the past week, the share price has fallen by 11.36%, sharply contrasting with the Sensex’s modest gain of 0.65% during the same timeframe. This underperformance extends over longer horizons, with the stock down 9.79% in the last month while the Sensex rose 1.43%. Year-to-date figures reveal a stark divergence, as Zenlabs Ethica has declined 31.67%, whereas the Sensex has appreciated by 8.96%. Over one, three, and five-year periods, the stock has consistently lagged the benchmark, with losses of 33.83%, 62.04%, and 11.07% respectively, compared to Sensex gains of 6.09%, 35.42%, and 90.82%. These figures highlight a prolonged period of under...
Read More
Zenlabs Ethica Falls to 52-Week Low of Rs.25.5 Amidst Continued Downtrend
2025-12-02 10:46:52Zenlabs Ethica, a player in the Diversified Commercial Services sector, has reached a new 52-week low of Rs.25.5, marking a significant point in its recent trading performance. The stock has experienced a sustained decline over the past few days, reflecting ongoing pressures within its market segment and company-specific factors.
Read MoreWhy is Zenlabs Ethica falling/rising?
2025-11-10 22:53:45As of 10-Nov, Zenlabs Ethica Ltd's stock price is currently at Rs 29.87, reflecting a decrease of Rs 1.97 or 6.19%. The stock has been underperforming, having fallen consecutively for the last two days, with a total decline of 6.66% during this period. Today's trading has shown high volatility, with the stock reaching an intraday high of Rs 34 and a low of Rs 29.5, indicating a wide trading range of Rs 4.5. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which suggests a bearish trend. Notably, investor participation has decreased significantly, with delivery volume dropping by 91.31% compared to the 5-day average, indicating a lack of confidence among investors. In the broader market context, Zenlabs Ethica's performance has been notably weaker than the benchmark Sensex, which has shown a slight decline of 0.53% over the past week, while Zenlabs ha...
Read MoreHow has been the historical performance of Zenlabs Ethica?
2025-11-09 22:48:06Answer: The historical performance of Zenlabs Ethica shows a declining trend in net sales and profit over the past few years, with net sales decreasing from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. The total operating income followed a similar pattern, dropping from 69.09 Cr in Mar'22 to 51.42 Cr in Mar'25. Operating profit (PBDIT) also saw fluctuations, peaking at 3.04 Cr in Mar'23 before falling to 2.61 Cr in Mar'25. Profit before tax decreased from 1.89 Cr in Mar'19 to 0.43 Cr in Mar'25, while profit after tax declined from 1.26 Cr in Mar'19 to 0.27 Cr in Mar'25. The earnings per share (EPS) reflected this downward trend, decreasing from 1.94 in Mar'19 to 0.41 in Mar'25. In terms of assets and liabilities, total assets increased from 33.65 Cr in Mar'20 to 40.38 Cr in Mar'25, while total liabilities also rose from 31.75 Cr in Mar'21 to 40.38 Cr in Mar'25. The company maintained a consistent share capit...
Read MoreAre Zenlabs Ethica latest results good or bad?
2025-11-09 19:14:44Zenlabs Ethica's latest financial results for Q2 FY26 reveal a complex operational landscape. The company reported a sequential revenue increase of 8.28%, reaching ₹12.43 crores, indicating some recovery in top-line performance compared to the previous quarter. However, this revenue growth comes against a backdrop of significant challenges, as net profit fell to ₹0.04 crores, reflecting a 20% decline from the prior quarter. This drop in profitability raises concerns about the company's ability to convert sales into sustainable earnings. Operating margins have also been under pressure, with the latest figure at 3.54%, down from 4.70% in the previous quarter. This decline in operating profitability highlights the ongoing struggle with rising operational costs that have outpaced revenue growth. The company's profit before tax was reported at ₹0.08 crores, but an unusually high tax rate of 50% further eroded n...
Read More
Zenlabs Ethica Q2 FY26: Struggling Micro-Cap Pharma Marketer Faces Margin Pressure and Valuation Concerns
2025-11-08 18:02:26Zenlabs Ethica Ltd., a micro-cap pharmaceutical contract marketing and trading company, reported a net profit of ₹0.04 crores for Q2 FY26, marking a marginal decline of 20.00% quarter-on-quarter but remaining flat year-on-year. With a market capitalisation of just ₹21.00 crores, the Chandigarh-based company continues to grapple with persistent margin erosion and underwhelming profitability despite a modest revenue uptick. Trading at ₹31.84 as of November 07, 2025, the stock has declined 0.50% in the latest session and remains down 27.39% over the past year, significantly underperforming the Sensex's 4.62% gain.
Read MoreCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
09-Jan-2026 | Source : BSECompliance Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the Quarter ended December 31 2025
Closure of Trading Window
29-Dec-2025 | Source : BSEThe Trading window will remain closed for all Directors/Promoters/Designated Persons and their immediate relatives of the company from Thursday 01st January 2026 till 48 hours after declaration of unaudited financial results for the quarter and nine months ended on 31st December2025
Announcement under Regulation 30 (LODR)-Change in Management
04-Dec-2025 | Source : BSEIntimation of change in Management due to Resignation of Company Secretary and Compliance Officer of the Company.
Corporate Actions
No Upcoming Board Meetings
Zenlabs Ethica Ltd has declared 2% dividend, ex-date: 29 Jul 22
No Splits history available
Zenlabs Ethica Ltd has announced 1:20 bonus issue, ex-date: 11 Oct 18
No Rights history available